• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Encorafenib-[d8]

General Information
Catalog: BLP-013478
Molecular Formula: C22H19D8ClFN7O4S
Molecular Weight: 548
Chemical Structure
Encorafenib-[d8]
Description Encorafenib-[d8] is the labelled analogue of Encorafenib. Encorafenib, also known as LGX-818, is an orally available Raf kinase inhibitor with potential antineoplastic activity.
Synonyms Encorafenib-d8; Braftovi-d8; LGX818-D8
Related CAS 1269440-17-6 (unlabelled)
Purity >95%; 98% atom D

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket